Valuation: Bayer AG

Market Cap 48.09B 55.49B 45.02B 41.08B 77.3B 5,293B 78.6B 528B 207B 2,649B 208B 204B 8,838B P/E 2026 *
20.7x
P/E 2027 * 15.7x
Enterprise Value 77.28B 89.18B 72.35B 66.01B 124B 8,506B 126B 848B 332B 4,257B 335B 328B 14,203B EV / Sales 2026 *
1.69x
EV / Sales 2027 * 1.6x
Free-Float
100%
Yield 2026 *
0.32%
Yield 2027 * 1.08%
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 60 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
-18.87%0.00% - - 55.49B
-0.66%+2.58%+87.67%+123.05% 1,083B
-0.74%-0.46%+48.41%+47.84% 626B
-0.69%-0.21%+24.46%+62.36% 442B
-1.68%-0.74%+46.92%+36.68% 363B
-1.57%-1.14%+27.86%+35.33% 295B
-1.17%-3.44%+4.83%+4.57% 248B
-0.37%+0.73%+44.16%+57.42% 224B
-2.91%+1.07%-7.19%-51.97% 210B
-0.09%+1.62%+11.56%+67.68% 168B
Average -2.88%+2.88%+32.07%+42.55% 406.57B
Weighted average by Cap. -1.24%+4.29%+47.23%+62.58%

Financials

2026 *2027 *
Net sales 45.69B 52.73B 42.78B 39.03B 73.45B 5,029B 74.68B 502B 197B 2,517B 198B 194B 8,398B 46.9B 54.12B 43.9B 40.06B 75.39B 5,162B 76.65B 515B 202B 2,584B 203B 199B 8,619B
Net income 2.18B 2.52B 2.04B 1.87B 3.51B 240B 3.57B 23.97B 9.39B 120B 9.46B 9.26B 401B 2.94B 3.39B 2.75B 2.51B 4.73B 324B 4.81B 32.28B 12.65B 162B 12.74B 12.46B 540B
Net Debt 29.19B 33.69B 27.33B 24.94B 46.92B 3,213B 47.71B 320B 126B 1,608B 126B 124B 5,365B 27B 31.16B 25.28B 23.07B 43.41B 2,972B 44.14B 296B 116B 1,488B 117B 114B 4,963B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
48.95EUR
Average target price
56.81EUR
Spread / Average Target
+16.05%

Quarterly revenue - Rate of surprise